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Abstract
In advanced stages of Parkinson Disease (PD), gait and postural abnormalities emerge. These
symptoms are not prominent at early stages of PD despite significant dopaminergic neuronal
loss. Gait abnormalities are largely not responsive to levodopa. Therefore, other types of
neurons might be responsible for gait abnormalities of the PD.
Since the reticulospinal tract (RET) is mainly implicated in the control of axial muscles, the
degeneration of this pathway or populations of neurons controlling this pathway might be
responsible for axial symptoms. However, there is limited data about the neurons controlling
the RET. Our aim in this study is to delineate these pathways.
We found that serotonergic projections from dorsal raphe nucleus (DRN) exert an important
control on the RET. Inhibition of the DRN resulted in severe episodes of gait freezing in rats.
Activation of 5HT1A receptors in the gigantocellular neurons changes muscle tone in rats
during gait. The DRN also sends projections to the mesencephalic locomotor region, which
are implicated in controlling dynamic gait parameters. DRN neurons receive nigral
dopaminergic projections and post-mortem studies in PD patients have identified significant
loss of DRN neurons; therefore DRN neurons may play a role in the pathophysiology of gait
abnormalities of PD.
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Chapter 1
« General Introduction »
Parkinson disease (PD) is the second most common neurodegenerative disease after
Alzheimer disease, affecting approximately seven million people worldwide. During the
early stages of PD, more than 80% of dopaminergic neurons in the substantia nigra pars
compacta are lost. This loss of dopamine leads to an array of motor symptoms, including
tremor, rigidity, and bradykinesia (Berg et al., 2015; Racette & Willis, 2015).

In advanced stages of PD, gait dysfunction, balance abnormalities, and impaired control
of complex movements emerge. These symptoms are not prominent in the early stages of
PD despite significant dopaminergic neuronal loss. Although levodopa is the main
therapeutic treatment to treat PD motor symptoms, gait abnormalities are largely not
responsive to this drug. Therefore, the postural and gait abnormalities of PD are not
believed to be isolated to dopaminergic cell loss (Sarter, Albin, Kucinski, & Lustig, 2014;
Virmani, Moskowitz, Vonsattel, & Fahn, 2015; Vorovenci, Biundo, & Antonini, 2015).

The reticulospinal tract (RET) is a well-known pathway implicated in locomotion,
postural adjustments, and reaching. This pathway regulates gross motor functions by
controlling motoneurons and central pattern generators (CPGs) of proximal and axial
muscles (Baker, 2011b; Schepens & Drew, 2004). Therefore, degeneration of this
pathway or the population of the neurons controlling this pathway might be responsible
for axial symptoms in advanced stages of PD.

Neuroanatomical studies have shown that the mesencephalic locomotor region (MLR)
and specifically the pedunculopontine nucleus (PPN) send projections down to the
gigantocellular nucleus (GiN), where the RET originates in the medulla (Skinner &
Garcia-Rill, 1984; Smetana, Juvin, Dubuc, & Alford, 2010); However, no study has
comprehensively investigated the connections between the PPN, other brainstem nuclei
and the CPGs and motoneurons of the spinal cord. In addition, several studies have
suggested that other populations of neurons including serotonergic neurons in the dorsal
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raphe nucleus (DRN) have a significant role in controlling motoneurons and locomotor
CPGs (Barreiro-Iglesias, Villar-Cerviño, Anadón, & Rodicio, 2008; Courtine et al., 2009;
Ghosh & Pearse, 2015).
In the next section, the role of CPGs, the serotonergic system and DRN, MLR, and GiN
in gait will be reviewed in detail.

1.1 « Central Pattern Generators »
There are two main states in all species of animals: 1) quiescence or sleep state and 2)
active or awake state. During each of these states, there are specific groups of neurons
that control basic repetitive behaviors such as respiration, swallowing, mastication,
locomotion, escape, as well as other rhythmic behaviors essential to the animals’ survival
(Gillette & Brown, 2015)
To generate rhythmic motor activities, precise spatiotemporal activation and inhibition of
neurons controlling these behaviors are needed. Such synchronization is the first
important property of this system. This type of spatiotemporal synchronization is found
mostly between neuronal networks in more primitive areas of the CNS including, the
spinal cord and brainstem (S. T. Alford & Alpert, 2014; Cherniak, Etlin, Strauss,
Anglister, & Lev-Tov, 2014b). Due to their intrinsic property to produce rhythmic
activity,

these

neuronal

networks

are

known

as

central

pattern

generators

(CPGs)(Buchanan & Cohen, 1982).
CPGs for locomotion are one of the most established circuits of the human body. They
are located in the ventral horn of the lumbosacral spinal cord and have a very high level
of automaticity (Grillner, 1985; Kiehn, 2006).
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In a successful gait cycle, while the muscles of one side of a body segment are
contracted, the muscles of the other side are relaxed. Glutamatergic excitatory neurons of
the ventral horn of the spinal cord play an important role in producing this pattern
(Buchanan & Cohen, 1982; Kiehn, 2006). These glutamatergic neurons innervate alpha
motoneurons bilaterally and inhibitory interneurons of the ipsilateral side, which in turn
send axons to the opposite side of the spinal cord and innervate the contralateral alpha
motor neurons. As a result, when glutamatergic interneurons become activated, they
excite both the motor neurons and ipsilateral inhibitory interneurons, innervating the
motor neurons of the opposite site. This leads to the excitation of the ipsilateral
motoneurons, and inhibition of contralateral motoneurons (S. T. Alford & Alpert, 2014;
S. Alford & Williams, 1989).
Automaticity is another essential property of the neurons in CPGs circuits (S. T. Alford &
Alpert, 2014). Studies have shown that the presence of a gradient for the level of
automaticity between upper and lower lumbar areas. This indicates that upper areas of the
lumbar spinal cord reproduce more automaticity compared to that of the lower areas
(Berkowitz, 2004).
In a recent study, optogenetic methods were employed in mice to specifically stimulate
glutamatergic neurons in CPGs. The results indicated that stimulation of these neurons
alone is enough to initiate and maintain perfect gait cycles in mice. In fact, these
networks of neurons are able to keep their rhythmic activity without any input from the
brainstem or sensory feedback from supra-spinal areas in CNS (Hägglund, Borgius,
Dougherty, & Kiehn, 2010). Constant exposure of these neurons to an NMDA receptor
agonist does not change their rhythmic activity. This phenomenon can be explained by
numerous inhibitory interneurons inside the network (Wallén & Grillner, 1987). In
addition, NMDA receptors on excitatory neurons in CPGs are Ca2+ dependent K+
receptors (Buchanan & Cohen, 1982). This means that a single neuron becomes activated
when glutamate binds to its receptor, but a calcium influx will eventually cause opening
of potassium channels, resulting in hyperpolarization of the cell (Hill, Matsushima,
Schotland, & Grillner, 1992). Therefore, even when neurons are exposed to Tetrodotoxin
(TTX), which prevents the synaptic communication between neurons, NMDA receptors
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are able to induce rhythmic activity in excitatory neurons of CPGs (Wallén & Grillner,
1987). These findings suggest that automaticity is an intrinsic characteristic of CPG
neurons and is not dependent on inputs from supra-spinal areas of the CNS (Buchanan &
Cohen, 1982; Buchanan & Grillner, 1987; Wallén & Grillner, 1987). An interesting fact
about the gait CPGs is that gait pattern can be changed without altering speed. This can
be explained by the existence of different types of neurons inside the CPGs, which each
control a different aspect of gait (Wilson et al., 2005).
The central nervous system receives many extrinsic and intrinsic sensorimotor stimuli
continuously, but the brain’s resources for responding to these stimuli are very limited.
To overcome this problem, highly specialized structures, such as the basal ganglia and
many

other

neuronal

networks

in

the

brainstem

have

developed

during

evolution(Stephenson-Jones, Samuelsson, Ericsson, Robertson, & Grillner, 2011). These
structures are responsible for identifying the salient stimuli and providing an appropriate
motor response through activation of relevant CPGs (Redgrave, Prescott, & Gurney,
1999; Stephenson-Jones et al., 2011).
In primitive animals such as invertebrates, the amount of incoming sensory information
and number of motor responses are very limited. As a consequence, the networks
controlling CPGs in these animals are significantly simpler compared to those of complex
animals including mammals (Cherniak, Etlin, Strauss, Anglister, & Lev-Tov, 2014a).
Moreover, the upper brain regions regulating CPGs are also able to control the different
aspects of gait. For instance, studies on lampreys suggest that the MLR is able to initiate
locomotion by stimulating locomotion CPGs in the ventral lumbar spinal cord. The MLR
is also able to control the speed of locomotion and muscle tone by sending commands to
locomotion CPGs (Smetana et al., 2010).
Gait is a very complex behavior in mammals and as a result, many neurotransmitters and
brain areas may control CPGs and motoneurons. To understand the gait mechanism,
learning about these neurotransmitters and supra-spinal centers is essential. Here we will
discuss the role of the most important neurotransmitters and anatomical areas involved in
controlling different aspects of CPGs’ function.
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1.2 « Raphe Nuclei and Serotonergic System»
Many studies suggest that serotonergic neurons play an essential role in controlling CPGs
in both invertebrates and vertebrates (Ghosh & Pearse, 2015; Veasey, Fornal, Metzler, &
Jacobs, 1995b). The mollusk is an invertebrate that diverged about 600 million years ago;
but their serotonergic system retains many similarities with vertebrates (Gillette, 2006).
5-Hydroxytryptamine (5-HT) neurons in these invertebrates are located in three main
motor CPGs, including the feeding, escape, and locomotion networks. The main role of
the serotonergic system in these three networks is the excitation of neurons, which leads
to activation of the CPGs. The serotonergic system is also important in controlling
different aspects of CPGs function such as, the footfall pattern in rodents (Gillette, 2006).
In general, the serotonergic system in both invertebrates and vertebrates facilitates the
spinal reflexes (Kiehn, 2006), but there are some key anatomical and physiological
differences across species.
One of the main differences in the serotonergic system of invertebrates and vertebrates is
the location of the neurons. As mentioned above, in invertebrates, serotonergic neurons
are located next to the motor CPG networks; however in all vertebrates (from lampreys to
mammals), most of the serotonergic neurons are concentrated in the raphe nuclei in the
midbrain (Barreiro-Iglesias et al., 2008). These 5-HT neurons mainly project to motor
nuclei in the brainstem and motor CPGs in the spinal cord (Veasey, Fornal, Metzler, &
Jacobs, 1995a). Electrophysiological studies show that these neurons increase their
activity during spontaneous behaviors like locomotion, feeding, and increased respiratory
tone following hypercapnia (Aghajanian & Vandermaelen, 1982; Veasey et al., 1995b).
In addition, there are strong inhibitory interconnections between different raphe nuclei
and even intrinsically within each of these nuclei. It is proposed that these inhibitory
interconnections are able to inhibit the activity of inappropriate CPGs and enhance the
activity of the relevant CPGs (Gillette, 2006). Interestingly, in almost all vertebrates,
projections of serotonergic neurons from the hindbrain to motoneurons in the spinal cord
happen at a very early stage of embryogenesis. This emphasizes the importance of this
system in controlling locomotion (Barreiro-Iglesias et al., 2008).
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Serotonergic neurons of the raphe nuclei demonstrate specific patterns of electrical
activity, which allows them to efficiently control CPGs. 5-HT neurons in the raphe nuclei
have a rhythmic pattern of activity. In these neurons, action potential duration is equal to
or more than 2 milliseconds, followed by a significant stage of after hyperpolarization
(Aghajanian & Vandermaelen, 1982; Miguelez, Grandoso, & Ugedo, 2011). In addition,
these neurons show significant reduction in their activity during sleep, specifically in the
period of REM. (Urbain, Creamer, & Debonnel, 2006). This reduction in activity during
sleep can be explained by increased production of melanin concentrating hormone
(MCH) and decreased level of orexin during sleep and specifically during REM. Both
MCH and orexin are secreted from the respective populations of neurons in the lateral
hypothalamus and it is proposed that they are important in controlling different aspects of
the sleep-awake cycle (Veasey et al., 1995a).

After complete spinal cord transection, invertebrates and primitive vertebrates such as
lampreys, recover from paralysis and are capable of moving normally again after a few
months (Chiasson, Baker, & Croll, 1994; Cornide-Petronio, Ruiz, Barreiro-Iglesias, &
Rodicio, 2011; Koert et al., 2001). Cornide-Petronio ME et al, (Cornide-Petronio et al.,
2011), showed that spontaneous regeneration of serotonergic descending projections are
mainly responsible for recovery of locomotion in lampreys. Using immunohistochemistry
methods, these authors have demonstrated that axons from serotonergic neurons in the
rhombencephalon or dorsal raphe regenerate to the levels below the transection.
Since CPGs are mainly controlled by the serotonergic system in more primitive animals
like lampreys, regeneration of serotonergic neurons is enough to recover locomotion.
However, in more complex vertebrates including mammals, the motor cortex and basal
ganglia also send projections to the spinal cord through the corticospinal tract, which
controls the voluntary aspect of locomotion (Murray et al., 2010).
Murray et al., (Murray et al., 2010) have also discovered that changes in post
transcriptional editing of 5HT2c receptor mRNA causes an over expression of new
receptor isoform on motoneurons after spinal cord injury. This isoform for 5HT2c
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receptor is able to become activated in the absence of serotonin neurotransmitters in the
spinal cord. This compensatory mechanism helps the motoneurons to regain their
excitability, which leads to sustained muscle contractions. However, due to the lack of
the regulatory commands from the brain, the rats developed muscle spasms for a few
days after the spinal cord injury.
In conclusion, the serotonergic system is responsible for turning the locomotion CPGs on
or off, however regulatory effect of other tracts such as reticulospinal tract, and
corticospinal tract from the supra-spinal areas is required for a successful goal-oriented
locomotion.

1.3 « Mesencephalic Locomotor Region »
Fifty years ago, Shik and colleagues identified the MLR for the first time. In a fascinating
experiment, they demonstrated that electrical stimulation of a small region in the dorsal
area of the mesopontine junction in unconscious decerebrated cats induced walking,
running, and even galloping depending on the frequency of stimulation (Shik, Severin, &
Orlovskiĭ, 1966). These findings in cats and similar findings in different species, such as
rodents and salamanders, suggest that the MLR is the gait initiation center (Cabelguen,
Bourcier-Lucas, & Dubuc, 2003; Skinner & Garcia-Rill, 1984). The MLR is part of the
reticular formation in the mesopontine junction and includes the cuneiform nucleus and
pedunculopontine tegmental nucleus (PPN) (Child & Benarroch, 2013). There are
numerous studies on the PPN and much research focuses specifically on the cholinergic
neurons of the PPN. These studies were designed to show the role of these neurons in gait
(Gut & Winn, 2015). However, the role of the cholinergic neurons in gait remains
controversial and in fact, many of these studies suggested that PPN cholinergic neurons
have no effect or a very minor effect on gait (Gut & Winn, 2015; Hernández-Chan et al.,
2011). In addition, PPN electrical stimulation in Parkinson disease patients suffering
from axial symptoms and freezing of gait were mostly unsuccessful (Ferraye et al.,
2010).
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More recent studies suggest a potential role of the PPN in gait because of its essential role
in integration of sensory information. For instance MacLaren et al., showed that the PPN
is not important in fixed gait speed and gait initiation in rats (MacLaren, Santini, Russell,
Markovic, & Clark, 2014). However, in accelerated rotarod studies, bilateral PPN
cholinergic neuronal loss resulted in severely impaired gait. Gait on a fixed speed rotarod
is considered an automatic and reflexive behavior. However, maintaining successful gait
on an accelerated speed rotarod requires the motor system to continuously adjust to
changes from incoming sensory inputs. The PPN receives fast sensory input and sends
projections to the substantia nigra pars compacta. These projections contain information
about the value and salience of the sensory information (Hong & Hikosaka, 2014).
Contrary to fixed speed performance, in accelerated speed gait, there is a continuous
change in the sensory information enters the PPN. Therefore, it is proposed that the PPN
is responsible for integration of sensorimotor information in complex motor tasks (Gut &
Winn, 2015; Hong & Hikosaka, 2014; MacLaren et al., 2014).
In addition, two different studies involving single-unit electrode recording from the PPN
in Parkinson disease patients while they were asked to imagine walking, showed
significant changes in electrical activity of neurons during gait imagination compared to
the resting state. These changes suggest that PPN is involved in planning gait (Lau et al.,
2015; Tattersall et al., 2014).
Therefore, while the PPN and specifically cholinergic neurons of the PPN are one of the
main suspects in controlling CPGs, well designed studies are needed to prove this claim.

1.4 « Medullary Reticular Formation »
The medial part of the rostral medulla has been implicated in the modulation of the axial
motor activity. It is composed of two main parts: the gigantocellular nucleus (GiN)
located dorsally, and the magnocellular nucleus (MN) located ventrally.
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The neurons of the GiN send glutamatergic projections down to the spinal cord CPGs via
the reticulospinal tract (Martin et al., 2011; Vetrivelan, Fuller, Tong, & Lu, 2009).
It is well known that electrical stimulation of the medial part of the rostral medulla
suppresses the muscle tone in both decerebrated normal animals during sleep and
wakefulness (Hajnik, Lai, & Siegel, 2000; Karlsson & Blumberg, 2005; Lai, Kodama,
Schenkel, & Siegel, 2010). In addition, cell body specific lesions of the glutamatergic
neurons in this area induces increased muscle tone and phasic muscle activity during both
REM and non-REM sleep (Vetrivelan et al., 2009) .
It is believed that the MLR controls the CPGs in the spinal cord through the
reticulospinal tract. The MLR sends bilateral and symmetric cholinergic projections to
the medulla, (Le Ray et al., 2003) (Rolland, Karachi, Muriel, Hirsch, & François, 2011)
and GiN in the medulla sends projections to the spinal cord CPGs via the RET. However,
it is not clear whether medullary neurons receive afferent projections from MLR do send
projections down to the spinal cord. Recent study by Sherman et al. (Sherman et al.,
2015) identified that MLR neurons send projections directly down to the CPGs in the
spinal cord. They also found that these neurons are not cholinergic neurons of the
pedunculopontine nucleus, but they are the fast spiking glutamatergic neurons located
anterior and posterior to the PPN.
In order to achieve successful goal oriented locomotion, appropriate body orientation and
posture is also needed. Studies have shown that the vestibular system in the medullary
reticular formation controls head orientation and balance by modulating the activity of
the reticulospinal pathway (Kolkman, Moghadam, & du Lac, 2011).
In conclusion, while there is no doubt that GiN glutamatergic neurons are important in
controlling muscle tone during both wakefulness and sleep, there is a big gap in our
knowledge about the brainstem areas controlling the RET and specifically the GiN in the
rostral medulla. Our aim from the review in this section is to:
a) Delineate the pathways controlling the RET and to determine their importance in
gait.
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b) Address these questions, by first performing tracer studies to locate the pathways.
c) Then by pharmacological studies, manipulate these pathways in rats and
d) Study their gait using the Catwalk XT apparatus.
Next, different methods for the rats’ gait assessment will be discussed and the advantage
of using the Catwalk apparatus over other methods will be explained.

1.5 « Methods for Gait Analysis in Rodents »
There are many available tests to analyze gait and locomotion in animals. The open field
measurement testing is commonly used by researchers to observe spontaneous
locomotion of an animal in an open field. This test is developed to measure general
locomotor activity and exploratory behavior in rodents. However, this test does not
provide detailed information about different phases of a gait cycle including stance phase
duration, swing phase duration, stride length, the intensity at which each paw contacts the
ground, and many other parameters (Mendes et al., 2015).
Another method commonly used to assess gait and locomotion is foot print analysis. In
this method, the paws of animals are dipped in ink and then the animals walk across a
strip of paper. This technique provides information regarding print area (length and
width) and stride length, but it is very difficult or even impossible to measure other
parameters of gait including the duration of each phase of the gait cycle or the footprint
intensity. In addition, controlling animals to walk on papers for several times is time
consuming and difficult (Neckel, 2015).
Catwalk XT is an automated gait analysis system, which consists of a long and enclosed
walkway with a glass plate floor (100* 12* 0.6 cm). It is designed to allow animals
traverse from one side of the walkway to the other freely with their natural speed. A
green light is illuminated to the glass plate and while the animals’ paws contact the glass,
the light becomes scattered. This scattering of light by the animals’ contacts is captured
by a high speed color video camera mounted below the glass. Then, the recorded videos
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are transformed into a series of digital images whereby each image is composed of
numerous pixels. Each pixel contains information about the brightness of the image at a
very small point and therefore reflects the intensity by which the animal’s paw touched
the glass plate at that point. As a result, this device is capable of measuring many
indices, and several studies have suggested that Catwalk testing provides valid data about
gait in animal models of spinal cord injury and neurodegenerative disorders as well as
Parkinson disease (Chuang et al., 2010; Vandeputte et al., 2010; Zhou et al., 2015). The
following tables (Table 1, and 2) summarize and define the static and dynamic gait
parameters that were analyzed in our study.

Table2. Static Gait Parameters and Their Definition
Static Gait Parameters
Max Contact Area (cm²)
Print Area (cm²)
Mean Intensity

Definition
Maximum area of a paw that comes into contact with the glass plate.
The surface area of the complete print.
The mean pressure the animal applies with each paw on the glass.

Table3. Dynamic Gait Parameters and Their Definition
Dynamic Gait Parameters
Stand (s)

Definition
The duration in seconds of a contact of a paw to the glass plate.

Swing (s)

The duration in seconds of no contact of a paw with the glass plate.

Swing Speed (m/s)

The speed (Distance Unit/second) of the paw during Swing.

Stride Length (cm)

The distance (in Distance Units) between successive placements
of the same paw.

Step Cycle(s)

The duration in seconds of stand + swing.

Duty Cycle (%)

Expressed Stand as a percentage of Step Cycle.

Body Speed (m/s)

The distance from one initial contact of one paw to the next by the
time to travel that distance.
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Body Speed Variation (%)

Dividing the absolute difference between the Body speed and the
Average Speed of a run by the Average Speed.

Stand Index

A measure for the speed at which the paw loses contact with the glass plate.

1.6 « Hypotheses and objectives of This Study »
The reticulospinal pathway is a phylogenetically old descending pathway, which mainly
controls the locomotion CPGs and motoneurons of axial and proximal muscles. It is
believed that this pathway is responsible for automatic and spontaneous control of
locomotion and body posture (Isa, Kinoshita, & Nishimura, 2013). However, pathways
and types of neurons and neurotransmitters involved in controlling the glutamatergic
neurons of this pathway are unknown. The main goal of this study is to investigate the
area(s) of the brain controlling reticulospinal tract neurons and determining their role in
gait. Based on the information we discussed above, we hypothesized that:

A) Either or both of DRN and MLR are sending axons to GiN to control reticulospinal
tract.
B) Since GiN controls muscle tone, the same region of the GiN controlling the
reticulospinal tract also controls muscle tone.
The objectives in this study are summarized here.
1. Identify brainstem area(s) controlling the reticulospinal pathway. This will be
discussed in detail in chapter 2.
2. Determine the importance of the region controlling the reticulospinal pathway in
gait. This part will be discussed in chapter 3.
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3. Identify neurotransmitters and receptor types controlling the reticulospinal
pathway at the rostral RF using both gait studies and immunohistochemistry. It
will be discussed in detail in chapter 4.
4. Determine whether DRN is important in controlling the MLR through gait studies
and immunohistochemistry. This will be discussed in detail in chapter 5.
5. Identify if 5HT1A autoreceptors on DRN serotonergic neurons are important in
controlling gait through gait studies and immunohistochemistry. This part will be
discussed in chapter 6.
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Chapter 2
« Identifying the pathways controlling the reticulospinal tract using neural
retrograde tracer Cholera Toxin Beta Subunit »
2.1 « Introduction »
Motoneurons in the spinal cord are controlled by two main groups of pathways: 1) the
corticospinal tract for fine motor tasks and 2) the reticulospinal tract for gross tasks
including locomotion, reaching, and posture (Baker, 2011a; Holstege & Kuypers, 1987).
In other words, in the corticospinal pathway, different combinations of neural activity in
the motor cortex leads to fine independent finger movements, while the reticulospinal
pathway controls more axial muscles to maintain posture and balance during locomotion
(Holstege & Kuypers, 1987; Lawrence & Kuypers, 1968).

The medial part of the rostral medulla has been implicated in the modulation of axial
motor activity. It is composed of two main parts: 1) GiN located dorsally and 2)
magnocellular nucleus (MN) located ventrally (Lawrence & Kuypers, 1968). Electrical
stimulation of the medial part of the rostral medulla suppresses the muscle tone in both
decerebrated and intact animals during sleep and wakefulness (Hajnik et al., 2000; Lai et
al., 2010; Vetrivelan et al., 2009).

It is believed that the MLR controls spinal cord CPGs through the RET. The MLR sends
bilateral and symmetric cholinergic projections down to the medulla in sea lampreys,
(Rolland et al., 2011) and the GiN in the medulla sends projections down to the spinal
CPGs via the reticulospinal tract (Martin et al., 2011). However, there is no study
showing that the neurons in the medulla which receive the projections from MLR are the
same ones projecting to the spinal cord. A recent study by Sherman et al. identified that
MLR neurons send projections directly down to the CPGs in the spinal cord. They also
found that these neurons are not cholinergic neurons of the pedunculopontine nucleus,
but they are fast spiking glutamatergic neurons located anteriorly and posteriorly to the
PPN. In addition, MLR neurons are not the only brainstem neurons controlling CPGs in
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the lumbar spinal cord. Many different types of neurotransmitters including different
subtypes of serotonergic receptors are identified on the surface of motoneurons (Ghosh &
Pearse, 2015; Noga, Johnson, Riesgo, & Pinzon, 2009). The serotonergic projections
arise mainly from the DRN(Barreiro-Iglesias et al., 2008), therefore other mesopontine
areas other than the MLR might also be important in controlling gait.

In this study, our first goal was to identify groups of neurons controlling the RET with
the use of a retrograde tracer, Cholera Toxin Beta subunit (CTB).

2.2 « Materials and Methods »

All animal procedures were approved by Animal Care and Veterinary services (ACVS) at
Western University, London, Ontario, Canada. Five male Sprague-Dawley rats
weighing 350-400 grams were used for the first part of the tracer study. Rats were
individually housed in Plexiglas-walled cages after the surgery with free access to
food and water. The temperature of the room was kept at 22±1 ºC on a 12 hour lightdark-cycle (lights on from 7 AM to 7 PM).

Surgical Procedure
For the first series of experiments, retrograde tracer Cholera Toxin beta subunit (CTB)
was microinjected in the ventral horn of the lumbar spinal cord. The animals were
anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80 mg/kg and
maintenance dose 40 mg/kg,) and xylazine (0.8 mg/kg,). Anaesthetized rats were
placed on a Kopf stereotaxic frame with spinal attachment (Kopf Instruments,
Tajunga, CA).
The retrograde tracer, Cholera Toxin Subunit ß (CTB) (Life Technologies) conjugated
with Alexa Fluor 594, was microinjected (0.5 µl of 1.0 mg/ml solution per site) in to the
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ventral horn of the lumbar spinal cord in 5 rats, using 10µl Hamilton syringe, mounted
and held by a Kopf Micro injector. To inject in the ventral horn of the lumbar spinal
(L2/3) cord, a small hole was drilled in the lamina close to the spinous process. Dura was
split to expose spinal cord. The syringe needle was lowered through the hole and spinal
cord vertically until it reached the stereotactic targets at the ventral horn of the spinal
cord, and the tracer was slowly injected over 3 minutes. After the injection, the needle
was kept in place for an additional 3 minutes. Surgical wound was closed with nylon and
skin clips. The rats were sacrificed 4 days after the surgery.

In another group of 10 rats weighting 250-270 grams, 0.5µl of 1 mg/ml CTB solution was
microinjected in the medial part of the rostral medulla using stereotaxic coordinates for
the GiN (AP= ˗11.0, M=0, DV= ˗9.0; Paxinos and Watson, 2007). These rats were
sacrificed 48 hours after surgery.

Histology
After completion of experiments, animals received an overdose of sodium pentobarbital
and were perfused transcardially with 0.9% NaCl containing 1 ml/lit heparin followed by
4% formaldehyde solution (in 0.05 M PB). The brains and spinal cords were removed
and kept in 4% formaldehyde solution for 48 hours and then 26% sucrose solution in PB
until they sink. Coronal sections (40 µm) through the entire length of the brainstem were
cut using a freezing sliding microtome. Every fifth section was mounted and the sections
were examined using Olympus FV1000 confocal microscope, and representative images
were digitally recorded.

2.3 « Results »
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CPGs are mainly controlled by three areas in the brainstem
A representative injection site is shown in figure 1. Based on previous studies, we
predicted that the CPGs in the ventral part of the spinal cord receive projections from two
main areas: 1) The medial zone of the rostral reticular formation where the GiN is located
and 2) The DRN (Fig2A, B). In addition to these two locations, we also found that CPGs
are also receiving direct projections from the MLR which is known as an important
center for gait initiation (Fig2c).

1mm
0.2mm

Figure1. CTB injection site at the
ventral horn of the lumbar spinal
cord.
Upper image shows the CTB
injection site at the ventral horn of
the lumbar spinal cord (white
arrow).

0.1mm

Lower image shows a section of the
ventral horn of the lumbar spinal
cord rostral to the injection site.
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A

B

C

Figure2. Neurons in three areas of the brain stem picked up the CTB
tracer GiN (A), DRN (B), and MLR (C). Scale bars = 50µm
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The reticulospinal tract receives strong projections from the DRN and not the MLR
In contrast to a general consensus regarding the control of the reticulospinal tract by
cholinergic neurons in the MLR, we found that the DRN sends projections down to
the GiN (Fig3). In addition, we examined many sections under the microscope to
find the neurons in the MLR area which would send projections down to the rostral
reticular formation. However, we did not see any labeling in that area.

A

B
Aqueduct

C

Aqueduct

Figure3. CTB Injection Site at GiN. Injection site is presented at GiN (white arrow) (A).
Neurons at DRN picked up the tracer: (B) shows 10 ˟ magnification, and (C) shows 40 ˟
magnification. Scale bars = 50µm
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2.4 « Discussion »
In the present study, we injected the neural retrograde tracer CTB at the ventral horn of
the lumbar spinal cord, where motoneurons and CPGs are located. Three main
locomotion related areas in the brainstem were labeled for the tracer: DRN, MLR,
and GiN. In a separate series of rats, we injected CTB in to the GiN. DRN neurons
were labeled by CTB, but there was no signal for the tracer in areas anterolateral to
the DRN where the MLR and PPN are located. In other words, we found evidence
for three parallel pathways from the brainstem to the motoneurons and CPGs inside
the spinal cord. The first pathway originates from the DRN directly, the second
pathway is coming indirectly from the DRN through the GiN, and the third pathway
arises from the MLR directly (Figure 2, and 3).
It is well known that many descending pathways including the corticospinal tract,
vestibulospinal tract, and rubrospinal tract also project to the ventral horn of the
spinal cord where lower motoneurons and CPGs are located (Isa et al., 2013), in the
current study, while the tracer might also be found in other brain areas besides the
MLR, DRN, and the GiN, we only focused on the brain stem structures which are
proposed to have a role in controlling the reticulospinal tract.
The direct pathway from the DRN to CPGs is very well known, and spinal cord injury
studies have shown that loss of serotonergic innervation in this pathway caused
severe impairment in gait in almost all species(Courtine et al., 2009). On the other
hand, stimulation of motoneurons by serotonin facilitates the gait and locomotion
cycle which emphasizes the role of the DRN direct pathway in controlling
motoneurons (Ghosh & Pearse, 2015; Noga et al., 2009; Veasey et al., 1995b).
Our findings on the other two pathways are against the prior literature about the MLR
and PPN, which suggested that these areas are the main structures sending
projections down to the GiN (Rye, Lee, Saper, & Wainer, 1988; Skinner & GarciaRill, 1984). In agreement with this, a recent study by Sherman et al. showed that the
MLR in the mesopontine junction does not send projections to the medullary
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reticular formation, rather does send direct projections down to the spinal cord
motoneurons.
While prior studies have shown that PPN cholinergic neurons are sending projections
down to the GiN, there are several recent studies suggesting that cholinergic neurons
in the PPN mostly send projections to the ventrolateral thalamic nucleus, and dorsal
striatum (Dautan et al., 2014; Wen et al., 2015).
Our current knowledge about the role of the MLR and PPN in gait stems mainly from
electrical stimulation studies. Since cholinergic neurons in the PPN send projections
up to the dorsal striatum and ventrolateral thalamic nucleus, the two subcortical
structures which are important in motor function, it is difficult to interpret the effect
of PPN stimulation on efferent pathways to the spinal cord, such as the RET. In
recent studies, low frequency stimulation of the PPN has been shown to produce
changes in neural activity in the ventrolateral thalamus, substantia nigra pars
reticulata, and sub thalamic nucleus (Park, Song, Jang, & Kim, 2014; Wen et al.,
2015). These three areas are affected in Parkinson disease and the studies suggested
that the therapeutic effect of PPN stimulation on gait and posture might stem from
the improvement in activity of these pathways.
On the other hand, deep brain stimulation of the PPN in PD patients does not always
show satisfactory outcome, and many animal and human studies suggest that PPN
stimulation is not improving gait and posture (Ferraye et al., 2010; Gut & Winn,
2015). In addition, studies have shown that the best area for deep brain stimulation is
posterior or even outside of the PPN (Ferraye et al., 2010; Gut & Winn, 2015;
Zrinzo, Zrinzo, & Hariz, 2007). Since the DRN is adjacent to the posterior part of
the PPN, it is possible that by stimulation of this area, neural activities of the DRN
neurons are also modified. This could be one of the mechanisms of gait
improvement during stimulation of the posterior PPN.
In conclusion, tracer studies have shown that DRN is sending projections to both the GiN
and motor neurons in the lumbar spinal cord. These findings imply that in addition
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to the MLR, the DRN may also plays an important role in controlling gait and
posture.
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Chapter 3
3 « Role of the Dorsal Raphe Nucleus in Gait. »

3.1 « Introduction »
In the first part of the study, we showed that serotonergic neurons of the DRN send
strong projections down to the GiN neurons of the medial part of the rostral reticular
formation.
Serotonergic neurons in the raphe nuclei in most species have a spontaneous rhythmic
activity. This pacemaker property is caused by intrinsic and gradual depolarizing ramps
observed in these neurons. This gradual depolarization results in an action potential
duration of 2 or more milliseconds, followed by a significant stage of after
hyperpolarization (Aghajanian & Vandermaelen, 1982; Urbain et al., 2006). Another
interesting property of these 5-HT neurons is their rate of firing during different states of
activity. Most of these neurons have the high rate of tonic activity during wakefulness
and show significant reduction in their activity during sleep. In fact, they are completely
silent during REM sleep, when the voluntary muscles are paralyzed (Urbain et al., 2006).
These properties make DRN serotonergic neurons good candidates for controlling
locomotion related CPG neurons in the lumbar spinal cord. Many studies suggest that
serotonergic projections to the motoneurons and CPGs play an essential role in
controlling CPGs and making gait patterns in both invertebrates and vertebrates(Kiehn,
2006). These studies employed electrophysiological recording during pharmacological
manipulation of motoneurons in in vitro slices of the spinal cord (Gackière & Vinay,
2014).
To the best of our knowledge, there are no studies analyzing gait parameters after
inhibition of the DRN nucleus in vivo in awake behaving animals. In this part of the
study, we inactivated DRN neurons by lidocaine and then analyzed the gait pattern while
the rats were spontaneously walking on Catwalk. It was hypothesized that inactivation of
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DRN projections to the motoneurons will result in abnormal foot fall pattern and
abnormal coordination between limbs.

3.2 « Material and Methods »
Six male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used.
Rats were individually housed in Plexiglas cages, with free access to food and water.
The room temperature was kept at 22±1 ºC on a 12 hour light-dark cycle (lights on
from 7:00 am to 7:00 pm).

Surgical Procedures
Animals were anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80 mg/kg
and maintenance dose 40 mg/kg, i.m.) and xylazine (0.8 mg/kg, i.m.). Anesthetized
rats were fixed in stereotaxic frame (Kopf Instruments, Tajunga, CA) and the incisor
bar was adjusted until the anterior and posterior parts of skull were horizontal.
Stereotaxic coordinates of Paxinos and Watson atlas (2007) were used and the
reference point was bregma. Indwelling stainless steel 27-g guide cannulae were
implanted 1.5 mm above the posterior border of the DRN. The coordinates are in
millimeters: AP= ˗8.3, M=0, DV= ˗6.4 for DRN. Following surgery, rats were
allowed to recover in their home cages for a period of 7 days.

Gait Studies

Gait parameters were measured using Catwalk XT (Noldus). While the animals are
traversing the walkway with their natural speed, a green light illuminates the glass plate
on the floor of the walkway. The light becomes scattered when the animals’ paws contact
the glass, and this will be recorded by a high-speed camera mounted below the glass. The
glass dimension is 100 cm length x 12 cm width x 0.6 cm thickness, which lets the
animals to complete at least 7 step cycles by walking up to 70 cm of the length. The
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definition of the gait parameters we measured in this study are summarized on Tables 3
and 4.
One day prior to the above surgical procedure, all rats underwent Catwalk training to
familiarize them to the walkway and to ensure their ability in conducting successful gait
trails.

Table3. Static Gait Parameters and Their Definition
Static Gait Parameters
Max Contact Area (cm²)
Print Area (cm²)
Mean Intensity

Definition
Maximum area of a paw that comes into contact with the glass plate.
The surface area of the complete print.
The mean pressure the animal applies with each paw on the glass.

Table4. Dynamic Gait Parameters and Their Definition
Dynamic Gait Parameters
Stand (s)

Definition
The duration in seconds of a contact of a paw to the glass plate.

Swing (s)

The duration in seconds of no contact of a paw with the glass plate.

Swing Speed (m/s)

The speed (Distance Unit/second) of the paw during Swing.

Stride Length (cm)

The distance (in Distance Units) between successive placements
of the same paw.

Step Cycle(s)

The duration in seconds of stand + swing.

Duty Cycle (%)

Expressed Stand as a percentage of Step Cycle.

Body Speed (m/s)

The distance from one initial contact of one paw to the next by the
time to travel that distance.

Body Speed Variation (%)

Dividing the absolute difference between the Body speed and the
Average Speed of a run by the Average Speed.

Stand Index

A measure for the speed at which the paw loses contact with the glass plate.
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At the first day of the experiment, a tight-fitting 30-g injection cannulae were inserted
into the guide cannula in such a way that protruded 1.5 mm from the tip of the guide
cannulae to reach the DV coordinates of the DRN. All Infusions were carried out over 1
minute and the injection cannulae were kept in place for an additional 60 seconds to
minimize back flow of the solution.
First, 0.5µl of sterile 0.9% saline was injected in DRN. Five minutes after the injection
the animals were placed on catwalk walkway, where they were able to walk freely with
their normal pace. For each vehicle or drug injection for each animal, three successful
gait trials were recorded. A successful gait trial is when the animal starts walking from
one side of the glass plate and finishes its gait to the other side of the glass without
turning back.
An hour after the saline injection, 0.5µl of sterile lidocaine hydrochloride 4% (Lidodan
4%) was injected in the DRN (Prado & Faganello, 2000), and five minutes after the
injection the rats were placed on catwalk and their gait was measured.
In the second day of the experiment, the same steps were repeated with administration of
1µl of lidocaine 4% in the DRN.
To verify the placement of the cannulae, 0.5µl of a 4% methylene blue solution was
infused in the DRN and the extent of the dye spread after half an hour was considered as
an indication of the presumed diffusion of the normal saline or Lidocaine which was
given to each animal during the experiments.

Statistical Analysis
In this study, gait parameters of six animals in each group were measured, similar studies
on Catwalk apparatus have shown that this number of the subjects provides a valid data
set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015).
All the recorded videos were double-checked to correct any possible errors that the
Catwalk software might have made in labeling the paws. All walkway crossings were
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ±
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to
analyze all parameters. Statistical significance was evaluated by the Friedman Test and
group differences were determined by the non-parametric Wilcoxon test. Since the
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number of the subjects we used in each group of the animals was small (n=6),
normalization of the data was not appropriate, therefore, we used Wilcoxon test that does
not assume normality in the data. In this study, a P value lower than 0.05 was considered
to be statistically significant.

3.3 « Results »
Verifying Cannulas Placement
Six male Sprague-Dawley rats underwent surgery and single cannulae were inserted in
the cerebral aqueduct adjacent to the posterior border of the DRN. To verify the
placement of the cannulae, 0.5µl of a 4% methylene blue solution was infused through
the cannulae and half an hour later animals were sacrificed. Frozen sections through the
brainstem were Nissl stained and the cannulae placement site was verified under the
microscope Figure4.

1mm
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Figure4. Low (A), and high (B) magnification of cannula site at cerebral aqueduct,
next to the dorsal border of DRN (black arrow) taken from two representative cases.
Nissl stained sections showing the intended position of the cannula tip. Infusions were
made just at the dorsal border of the DRN to prevent mechanical damage to the
nucleus. In some cases, cannula tip has just penetrated the DRN (A).
Effect of DRN inhibition by 0.5µl Lidocaine 4% on gait:
The vehicle’s effect on gait was tested by injection of 0.5 µl normal saline in the DRN
and studying the rats’ gait on Catwalk. Inhibition of DRN by 0.5µl Lidocaine 4%
impaired both static (Table 5) and dynamic (Table 6) gait parameters significantly.
Among static parameters, maximum contact area in forelimbs and print area in all
limbs are significantly decreased. Although almost all other static parameters
including maximum intensity and stand index are also decreased, the changes are not
statistically significant (Table 5).

Table 5. Static Gait Parameters after Injection of Lidocaine:
Mean ± standard deviation is measured for each parameter in
individual limbs. P values<0.05 are considered significant and
are highlighted with light green color.

Static Gait Parameters
MaxContactArea (cm²) RF
MaxContactArea (cm²) RH
MaxContactArea (cm²) LF
MaxContactArea (cm²) LH
PrintArea (cm²) RF
PrintArea (cm²) RH
PrintArea (cm²)LF
PrintArea (cm²)LH
Max Intensity RF
Max Intensity RH

Normal
Saline
4.2±0.99
3.6±1.29
4±0.78
3.96±1.6
5.88±1.64
4.86±1.68
5.9±1.65
5.2±1.96
192.6±17.4
190±21.6

Lidocaine
2.99±0.44
3.1±0.84
3.08±0.30
3.13±0.89
3.7±0.53
4.07±0.9
3.9±0.36
3.9±0.91
182.6±18.4
170±31.4

P
Value
0.046
0.345
0.046
0.463
0.046
0.028
0.046
0.028
0.345
0.249
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Max Intensity LF
Max Intensity LH
Mean Intensity RF
Mean Intensity RH
Mean Intensity LF
Mean Intensity LH
Stand Index RF
Stand Index RH
Stand Index LF
Stand Index LH

189.4±11.2
179.5±31.2
71.74±3.6
78.3±11.4
71.3±5.1
78.1±14.2
4.2±0.75
2.2±0.4
4.4±0.92
2.2±0.44

183±21.1
177±22
73.27±6.46
74.4±11.9
73.6±7.6
77.3±13
3.2±0.87
1.5±0.3
3.4±0.82
2.1±0.5

0.345
0.6
0.463
0.6
0.6
0.753
0.075
0.046
0.116
0.463

In addition, most of the time dependent parameters or dynamic parameters significantly
changed (Table 6). Each step cycle is made of two parts: stand and swing. The data
shows that both of these two parameters were significantly longer in lidocaine
treated rats. However, the duty cycle did not change, which suggests the ratio
between stand and swing duration in each step cycle remain constant. While the rats
were walking on Catwalk, several episodes of freezing happened during each trial
after lidocaine injection. The freezing episodes are represented as a significant
increase in body speed variation in all four limbs (p value= 0.028). This variation
occurs because a gait freezing episode produces a dramatic reduction in body speed.
The key findings in this part are also summarized in Figure5 and 6.

Table 6. Dynamic Gait Parameters after Injection of Lidocaine:
Mean ± standard deviation is measured for each parameter in
individual limbs. P values<0.05 are considered significant and
are highlighted with light green color.
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Dynamic Gait Parameters
Stand (s) RF
Stand (s) RH
Stand (s) LF
Stand (s) LH
Swing (s) RF
Swing (s) RH
Swing (s) LF
Swing (s) LH
Swing Speed (cm/s) RF
Swing Speed (cm/s) RH
Swing Speed (cm/s) LF
Swing Speed (cm/s) LH
Stride Length (cm) RF
Stride Length (cm) RH
Stride Length (cm) LF
Stride Length (cm)LH
Step Cycle (s)RF
Step Cycle (s) RH
Step Cycle (s) LF
Step Cycle (s)LH
Duty Cycle (%) RF
Duty Cycle (%)RH
Duty Cycle (%)LF
Duty Cycle (%)LH
Body Speed (cm/s) RF
Body Speed (cm/s) RH
Body Speed (cm/s) LF
Body Speed (cm/s) LH
Body Speed Variation (%) RF
Body Speed Variation (%) RH
Body Speed Variation (%) LF
Body Speed Variation (%) LH

Normal
Saline
0.34±0.06
0.46±0.09
0.34±0.08
0.44±0.12
0.22±0.04
0.125±0.02
0.18±0.05
0.135±0.04
94.97±23.4
130.2±17.1
107.67±10.56
129.07±7.74
14.28±1.8
15.6±1.45
13.2±2.5
14.9±1.8
0.59±0.12
0.6±0.12
0.53±0.1
0.6±0.14
63.35±4.1
74.98±3.89
63.6±4.3
74.36±3.9
25.4±3.85
26.1±3.8
25.7±3.5
26.6±4.3
41.8±10.4
42.4±13.5
45.1±12.4
41.0±10.3

P
Lidocaine
Value
0.8±0.6
0.046
1.22±1.1
0.028
0.69±0.39
0.046
1.3±0.9
0.028
0.29±0.11
0.046
0.14±0.03
0.028
0.5±0.4
0.046
0.17±0.05
0.028
83.3±24.6
0.345
110.5±31
0.116
109.04±13.3
0.028
149.39±35.9
0.249
12.4±1.3
0.116
13.7±0.9
0.046
13.1±1.4
0.917
13.3±1.8
0.345
1.01±0.4
0.046
1.1±0.6
0.028
1.25±0.9
0.028
1.25±0.7
0.028
67.45±5.8
0.116
78.4±3.79
0.075
65.7±4.6
0.173
73.4±2.00
0.917
19.6±5.88
0.075
21.02±4.8
0.028
19.65±5.4
0.116
20.5±5.4
0.249
86.3±30.3
0.028
88.6±32.4
0.028
81.5±17.8
0.028
85.2±28.6
0.028
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Figure5. Key findings of the performance on the Catwalk for static gait
parameters after injection of 0.5µl normal saline and after injection of 0.5µl
Lidocaine 4% in DRN. Graphs show group means ± SEM of selected gait
parameters. * p<0.05
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Figure6. Key findings of the performance on the Catwalk for dynamic gait
parameters after injection of 0.5µl normal saline and after injection of 0.5µl
Lidocaine 4% in DRN. Graphs show group means ± SEM of selected gait
parameters. * p<0.05

One day after the first experiment 1µl of lidocaine was microinjected in DRN. Five
minutes after the injection, rats were placed on Catwalk. While the rats were
completely conscious and their reflexes intact, they experienced several episodes of
severe freezing. Therefore, the Catwalk apparatus was not able to record their gait.
In very rare experiments that rats were able to walk, their footfall patterns were
totally irregular (Figure 7).

A

B

C

Figure7. Foot fall pattern after normal saline injection in DRN (A), 0.5µl
Lidocaine 4% injection in DRN (B), and 1µl Lidocaine 4% injection in DRNN
(C). One episode of freezing of gait is seen in image B, but the foot fall pattern
is preserved. Footfall pattern is completely irregular in image C.
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3.4 « Discussion »
In this part of the study, we found that partial inhibition of the DRN in rats using 0.5 µl of
lidocaine results in significant impairment in static gait parameters including
maximum contact area, and print area, as well as many dynamic gait parameters
including stand, swing, step cycle, and body speed variation. We also injected 1µl of
lidocaine in the DRN of rats and this time we were not able to record their gait due
to severe freezing of gait in these animals.
In mammals, serotonergic projections from the DRN are among the very first axons to
reach the motoneurons in the spinal cord (Barreiro-Iglesias et al., 2008; Vinay et al.,
2002). Reduced 5HT secretion in early days after birth in rodents resulted in postural
asymmetry and abnormal gait, which implies the importance of 5HT secretion from
DRN projections in development of interconnections between CPGs (Pflieger,
Clarac, & Vinay, 2002; Vinay et al., 2002). Injection of a 5HT2 receptor agonist
induced alternating air stepping in intact newborn rats (Brumley, Roberto, & Strain,
2012), and in vitro experiments on isolated spinal cord preparations of rats also
suggested that activation of 5HT2 receptors induce normal right/left and
extensor/flexor pattern (Nakayama, Nishimaru, & Kudo, 2002). Since these studies
all suggest that activation of 5HT receptors are playing an important role in inter and
intra-limb coordination, many studies designed for transplantation of embryonic
serotonergic neurons under the lesion site in spinal cord injury rodent models and
surprisingly many of these studies found this treatment effective (Majczyński,
Maleszak, Cabaj, & Sławińska, 2005; Sławińska et al., 2013).
Projection of DRN serotonergic neurons is not confined to motoneurons and CPGs.
There are considerable number of 5HT1A receptors on GABA interneurons and
layer V pyramidal cells of motor cortex (Kruglikov & Rudy, 2008; Puig, Artigas, &
Celada, 2005). In a study by Scullion et al., the 5,7 DHT neurotoxin was
microinjected into the lateral ventricle which resulted in widespread depletion of
serotonin specifically in cortex. The rats developed significant forelimb movement
impairment in skilled reaching movements. They also demonstrated that 5HT1A
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receptor knock out mice had significantly smaller motor maps compared to wild
type mice.
These studies suggest that DRN serotonergic projections to the motoneurons and motor
cortex are essential in limb coordination and thus, animals’ locomotion. However,
no study has focused on the effect of direct DRN inhibition in gait parameters.
Based on the above studies, we were expecting to see significant changes in dynamic
parameters and significant impairment in limb coordination. However, we also
found that static parameters are also significantly impaired. Maximum contact area
was decreased in forelimbs and print area was decreased in all four limbs. While
changes of these two indices are dependent on muscle tone in limbs, these findings
suggest that DRN neurons are also important in controlling the muscle tone during
locomotion. Muscle tone is mainly controlled by the rostral medullary reticular
formation or GiN. Therefore these findings are consistent with the tracer study
findings in previous chapter, where we showed that the DRN sends projections to
the GiN.
To prove this claim, we designed a study to manipulate neurons in the GiN by injection
of different serotonergic receptors agonists and antagonists, while measuring the rats
gait on Catwalk.
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Chapter 4
«Dorsal Raphe Nucleus Controls Reticulospinal Tract Neurons In
Gigantocellular Nucleus through 5HT1A and 5HT2 receptors. »

4.1 « Introduction »
Electrical stimulation of the medial part of the rostral medulla suppresses the muscle tone
in both decerebrated and intact animals during sleep and wakefulness (Hajnik et al.,
2000; Karlsson & Blumberg, 2005; Lai et al., 2010).There are several studies
suggesting that the group of gigantocellular nucleus neurons send projections down
to the spinal CPGs through the reticulospinal tract are glutamatergic (Martin et al.,
2011; Vetrivelan et al., 2009). Cell body specific lesions of these glutamatergic
neurons induces increased muscle tone and phasic muscle activity during both REM
and non-REM sleep (Vetrivelan et al., 2009). However, there is not enough
information about the detailed connectivity of these neurons and the type of the
projections that these glutamatergic neurons are receiving.
In the past two chapters, it was shown that microinjection of the retrograde neural tracer
CTB in the GiN of rats labeled serotonergic neurons of the dorsal raphe nucleus.
Subsequently, to understand the role of these serotonergic neurons in gait, we
injected Lidocaine into the DRN and studied rats’ gait by Catwalk apparatus. We
found a significant impairment in both static and dynamic parameters of gait in
those rats. Moreover, with higher doses of the Lidocaine (1µl of Lidocaine 4%), the
rats completely froze and recording their gait was almost impossible.
The next steps of this study were designed to uncover the subtypes of serotonergic
receptors controlling reticulospinal neurons in the GiN, and their specific roles in
gait.
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Since there are 7 serotonin receptor classes and at least 13 known serotonin receptor
subtypes in the brain (Raymond et al., 2001), it was difficult to study agonists and
antagonists for all of these receptors in order to identify which receptors are located
on GiN neurons. However, from previous studies, it is known that two types of
receptors are abundantly found on the surface of motoneurons in the spinal cord,
which are the 5HT1A and 5HT2 receptors (Courtine et al., 2009; Ghosh & Pearse,
2015; Murray et al., 2010). While the ligand (serotonin neurotransmitter) is the same
for these two receptors, their activity is completely opposite. 5HT2 receptors are
excitatory and their excitation on motoneurons facilitates gait. In contrast, 5HT1A
receptors are inhibitory and their activation induces hyperpolarization in neurons
(Scullion et al., 2013).
Here we hypothesized that injection of 5HT1A and 5HT2 agonists and antagonists
respectively, will change the muscle tone in rats while they are walking on Catwalk.

4.2 « Materials and Methods »
Six male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used.
Rats were individually housed in Plexiglas cages, with free access to food and water.
The room temperature was kept at 22±1 ºC on a 12 hour light-dark cycle (lights on
from 7:00 am to 7:00 pm).
Surgical Procedures
Animals were anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80 mg/kg
and maintenance dose 40 mg/kg, i.m.) and xylazine (0.8 mg/kg, i.m.). Anesthetized rats
were fixed in stereotaxic frame (Kopf Instruments, Tajunga, CA) and the incisor bar was
adjusted until the anterior and posterior parts of skull were horizontal. Stereotaxic
coordinates of Paxinos and Watson atlas (2007) were used and the reference point was
bregma. Indwelling stainless steel 27-g guide cannulae were implanted 1.5 mm above the
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GiN. The coordinates are in millimeters: F= ˗11, L=0, H= ˗9 for GiN. These rats were
kept in their cages for a 7 days of recovery period.
Drugs
8OH-DPAT (8-HYDROXY-2-(DI-n-PROPYLAMINO)TETRALIN) and Ketanserin
tartrate were purchased from Tocris Cookson (Ellisville, MO, USA).
Gait Studies
One day prior to surgery, all rats underwent Catwalk training to familiarize them to the
walkway and to ensure their ability in conducting successful gait trails.
Tight fitting 30-g injection cannulae were inserted into the guides. They protruded 1.5
mm from the guide cannulae to reach the coordinates mentioned above for the GiN.
Infusions were carried out over 1 minute and the injection cannulae were kept in place for
another 60 seconds to minimize backflow.

On the first experimental day, 0.5µl of sterile 0.9% saline was injected in the GiN. Five
minutes after the injection, the animals were placed on the Catwalk apparatus, where they
were able to walk freely with their normal pace. For each vehicle or drug injection of
each animal, at least three successful gait trials were recorded. A gait trial is considered
successful if the animal starts walking from one side of the glass plate and completes its
gait to the other side of the glass without turning back.
An hour after the saline injection, 10µM of sterile 8OH-DPAT (Pham-Le, Cockburn,
Nowell, & Brown, 2011) was injected in the GiN. Five minutes after the injection, the
rats were placed on Catwalk and their gait was measured. Few days later, the same steps
were repeated with 0.5µg/0.5µl Ketanserin tartrate, a 5HT2A/2c antagonist (McCool,
Christian, Fetzer, & Chappell, 2014) instead of 8OH-DPAT.
Histology
Upon completion of experiments, animals received an overdose of sodium pentobarbital
and were perfused transcardially with 0.9% NaCl (containing 1 ml/lit heparin) followed

38

by 4% formaldehyde solution (in 0.1 M phosphate buffer). The brains and spinal cords
were removed and kept in 4% formaldehyde solution for 48 hours and then 26% glycerol
solution until they sink.
To visualize colocalization of the CTB retrograde tracer (from animals in chapter 2, in
which CTB was microinjected in CPGs) with 5HT1A and 5HT2 in the GiN, 40µm coronal
sections were cut using a microtome and every fifth section was stained for 5HT1A or
5HT2 receptors.
A rabbit anti-5HT1A primary antibody (SR-1A Antibody, Santa Cruz Biotechnology) and
a Biotinylated Goat Anti-Rabbit IgG secondary antibody (Vector Laboratories) were
used. The primary antibody for 5HT2 receptors was a goat anti-5HT2 antibody (SR-2c
Antibody, Santa Cruz Biotechnology) and the secondary antibody was a Biotinylated
rabbit Anti-Goat IGg Antibody (Vector Laboratories).Then, sections were studied under
Olympus FV1000 microscope.
To verify the placement of the cannulae, 1µl of a 4% methylene blue solution was
infused in the GiN and the extension of the dye after half an hour was considered as an
indication of the presumed diffusion of the normal saline or the drugs which were given
to each animal during the experiments.
Statistical Analysis
In this study, gait parameters of six animals in each group were measured, similar studies
on Catwalk apparatus have shown that this number of the subjects provides a valid data
set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015).
All the recorded videos were double-checked to correct any possible errors that the
Catwalk software might have made in labeling the paws. All walkway crossings were
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ±
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to
analyze all parameters. Statistical significance was evaluated by the Friedman Test and
group differences were determined by the non-parametric Wilcoxon test. Since the
number of the subjects we used in each group of the animals was small (n=6),
normalization of the data was not appropriate, therefore, we used Wilcoxon test which
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does not assume normality in the data. In this study, a P value lower than 0.05 was
considered to be statistically significant.

4.3 « Results »
Verifying Cannulas Placement
To verify the placement of the cannulae, 1µl of a 4% methylene blue solution was
infused through the cannulae and half an hour later animals were sacrificed. Sections
were prepared and the cannulae sites were verified under the microscope Figure 8.

Figure8. Cannula site at GiN (black
arrow). Methylene blue 4% was
microinjected through cannulae. After
making sections Nissl staining with neutral
red color is done on the sections.

1mm

Effect of 5HT1A agonist, 8OH-DPAT injection in the GiN on gait.
After injection of the vehicle (normal saline) the animal’s baseline normal gait was
recorded on the Catwalk. One hour later, 10 µM of 8OH-DPAT, a 5HT1A agonist (PhamLe et al., 2011) was microinjected in the GiN and then the rats were placed on the
Catwalk again . The findings showed significant decrease in static parameters including
maximum contact area, print area, and maximum intensity, which suggest that the 5HT1A
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antagonist is affecting the muscle tone of limbs during gait. In contrast to static
parameters, there was no significant change in any of the dynamic parameters including
body speed variation (See Table 7).
Table7. Selected dynamic and static gait parameters after
injection of 8OH-DPAT in GiN. Mean ± standard deviation
is measured for each parameter in individual limbs. P values
< 0.05 are considered significant and are highlighted with
light green.

Gait Parameters
Max Contact Area RF
Max Contact Area RH
Max Contact Area LF
Max Contact Area LH
Print Area RF
Print Area RH
Print Area LF
Print Area LH
Body Speed RF
Body Speed RH
Body Speed LF
Body Speed LH
Body Speed Variation RF
Body Speed Variation RH
Body Speed Variation LF
Body Speed Variation LH
Max Intensity RF
Max Intensity RH
Max Intensity LF
Max Intensity LH

Normal
Saline
2.44±0.35
2.13±0.49
2.69±0.36
2.09±0.6
2.9±0.42
2.77±0.58
3.11±0.36
2.65±0.7
32.9±4.9
31.5±5.1
31.1±5.58
31.7±5.4
50.66±35.7
55.01±40.6
52.3±36.3
52.26±30.2
190.4±7.8
165.8±20
192.5±7.07
158.4±28.4

8OH-DPAT
1.95±0.66
1.4±0.49
2.01±0.4
1.2±0.5
2.3±0.8
1.74±0.57
2.35±0.47
1.5±0.6
29.2±8.6
28.6±8.8
27.3±8.8
28.7±9.2
45.5±15.7
46.9±17
42.8±12.5
47.9±16.9
169.2±21.8
134.2±32.5
164.9±20.8
121.6±26.2

p
value
0.249
0.075
0.046
0.028
0.249
0.046
0.046
0.028
0.345
0.249
0.249
0.345
0.917
0.753
0.917
0.6
0.116
0.046
0.028
0.028

Effect of 5HT2 antagonist, Ketanserin Tartrate injection in GiN on gait.
In a subsequent experiment, the rats’ baseline gait was recorded after 0.5 µl normal
saline. Subsequently, the same animals were microinjected in their GiN with 0.5µg/0.5µl
Ketanserin tartrate, a 5HT2A/2C antagonist (McCool et al., 2014) one hour later, and then
their gait was studied (see Table 8). The findings suggest that the only gait parameter that
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changed significantly was body speed variation. Therefore, in contrast to 5HT1A
receptors, 5HT2A/C receptors were demonstrated as not being involved in controlling
static parameters.
Table 8. Selected dynamic and static gait parameters. Mean ±
standard deviation is measured for each parameter in individual
limbs. P values < 0.05 are considered significant and are
highlighted with light green.

Gait Parameters
MaxContactArea RF
MaxContactArea RH
MaxContactArea LF
MaxContactArea LH
PrintArea RF
PrintArea RH
PrintArea LF
PrintArea LH
Body Speed RF
Body Speed RH
Body Speed LF
Body Speed LH
Body Speed Variation RF
Body Speed Variation RH
Body Speed Variation LF
Body Speed Variation LH
Max Intensity RF
Max Intensity RH
Max Intensity LF
Max Intensity LH

Normal
Saline
3.1±0.5
2.7±0.66
3.25±0.5
2.94±0.9
3.8±0.6
3.6±0.7
3.95±0.7
3.84±1.3
37.8±10.9
34.9±9.6
35.5±10
37.9±11.6
49.3±18.4
56.2±27.05
47.2±16.7
54.6±20.8
200.7±3.5
185±15.2
200.2±7.8
184.4±26.4

p
Ketanserine value
0.463
3.27±0.66
0.249
2.9±0.9
0.917
3.21±0.5
0.6
3.08±0.8
0.345
3.88±0.7
0.249
3.8±1.09
0.6
3.8±0.5
0.6
4.01±1.25
39±9.3
0.917
37.5±9.3
0.917
36±9.7
0.917
37.8±9.7
0.046
33.7±10.3
0.046
37.2±10.6
0.046
33.5±10.6
0.046
39.1±8.6
0.116
203.4±3.4
0.463
191±25
0.463
202.7±4.8
0.463
191.8±14.2

The key findings in this part of the experiment are summarized in Figure 9.
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Figure9. Key findings of the performance on the Catwalk for dynamic gait
parameters after injection of normal saline, 5HT1A agonist, and 5HT2 antagonist.
Graphs show group means ± SEM of selected gait parameters. * p<0.05
Immunohistochemistry Labeling for 5HT1A, and 5HT2 Receptors in GiN.
Here we found that both 5HT1A and 5HT2c receptors are present on the surface of the
neurons which were previously labeled for CTB injected in CPGs in the lumbar spinal
cord (Figure 10, and 11).
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A
Figure 10. Double Labeling of GiN
neurons for CTB tracer, and 5HT1A receptor
antibody. (A) CTB was injected in CPGs in
the ventral horn of the spinal cord. CTB
vesicles in GiN neurons axons and cell
bodies are seen in this image. (B) GiN
neurons stained for 5HT1A receptor
antibody. (C) Double staining of GiN
neurons for CTB and 5HT1A receptors
antibody

B

C
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A

B

C

Figure 11. Double Labeling of GiN
neurons for CTB tracer, and 5HT2C receptor
antibody. (A) CTB was injected in CPGs in
ventral horn of the spinal cord. CTB
vesicles in GiN neurons axons and cell
bodies are seen in this image. (B) GiN
neurons stained for 5HT2C receptor
antibody. (C) Double staining of GiN
neurons for CTB and 5HT2c receptors
antibody. Scale bars = 50 µm
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4.4 « Discussion »
The present study provides evidence that GiN descending neurons are controlled by
serotonergic projections. Among more than 30 known serotonergic receptor subtypes, we
examined the activity of two main receptors: 5HT1A and 5HT2 family receptors. We
found that 5HT1A receptors stimulation caused significant decrease in maximum contact
area, print area, and maximum intensity. Also, 5HT2 receptors inhibition only decreased
body speed variation significantly.
Our finding about the role of the GiN in controlling muscle tone is consistent with the
findings in many previous studies (Hajnik et al., 2000; Karlsson & Blumberg, 2005; Lai
et al., 2010; Martin et al., 2011; Vetrivelan et al., 2009). However, in almost all of these
studies, the methods that were used involved electrical stimulation or inhibition of the
neurons in the GiN. These studies suggested that the GiN causes atonia during REM
sleep (Vetrivelan et al., 2009). Since the DRN changes its level of activity during
different sleep cycles (Urbain et al., 2006) and during wakefulness, it can efficiently
control GiN neurons.
In previous chapter, we showed that general inhibition of the DRN by lidocaine resulted
in impairment of both dynamic and static gait parameters. The dynamic parameters were
impaired because of the inhibition of DRN serotonergic projections to the motoneurons
and CPGs in spinal cord. It is possible that the static parameters were impaired due to
changes in activity of DRN projections to GiN neurons.
One of the biggest controversies about the MLR or PPN’s role in controlling the
reticulospinal tract is the lack of evidence demonstrating changes in muscle tone or body
posture after stimulation or destruction of these structures in numerous studies, which
were conducted to date (Gut & Winn, 2015; Hernández-Chan et al., 2011; MacLaren et
al., 2014).
In a recent study by Gut et al, Catwalk was used to measure different gait parameters in
the 6-OHDA model of PD rats with partial or complete PPN lesions. They only found
significant changes in stride length, swing speed, and duty cycle of these rats. These
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changes improved after posterior PPN deep brain stimulation and worsened with anterior
PPN stimulation. However, they did not report any changes in any static gait parameters.
In conclusion, while review of literature about the role of the PPN and MLR in gait
improvement and control of reticulospinal tract is inconclusive, we found that the DRN is
a new target which plays an essential role in controlling both muscle tone and dynamic
parameters of gait.
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Chapter 5
«5HT1A Receptors On Mesencephalic Locomotor Region Neurons
Are Responsible for Dynamic Gait Parameters. »

5.1 « Introduction »
Shik and colleagues stimulated the dorsal area of the mesopontine junction in
unconscious decerebrated cats by electrodes. Their research showed that with lower
frequency stimulation of this area, the animals started to walk. With higher frequency
stimulation, the walking pattern of movement changed to running and even galloping
(Shik et al., 1966). Since that time, the dorsal area of the mesopontine junction has been
identified as the mesencephalic locomotor region (MLR). These findings in cats and
other similar findings in other species, like rodents and salamander, suggest that the MLR
is the gait initiation center (Cabelguen et al., 2003; Skinner & Garcia-Rill, 1984). The
MLR is part of the reticular formation in the mesopontine junction and includes the
cuneiform nucleus and pedunculopontine tegmental nucleus (PPN) (Child & Benarroch,
2013).
Previous studies suggest that serotonergic projections from the DRN have facilitatory
effects on motoneurons and CPGs (Noga et al., 2009). In this study, we showed that the
DRN play an essential role in controlling gait. In fact, inhibition of these neurons by
lidocaine resulted in severe impairment in animals’ gait (Chapter 3). We also
demonstrated that the DRN may be responsible in controlling muscle tone in rats by
sending axons down to the GiN. Therefore, it seems that the DRN is one of the main
centers of controlling locomotion in vertebrates. Since the MLR is known as an important
gait initiation center, we hypothesized that the DRN is controlling the MLR through
5HT1A receptors. To test our hypothesis, we microinjected a 5HT1A agonist
(8OH_DPAT) in the MLR region bilaterally and then studied the animals’ gait on
Catwalk.
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5.2 « Material and Methods »
Ten male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used.
Rats were individually housed in Plexiglas-walled cages with free access to food and
water throughout the experiment. The temperature of the room was kept at 22±1 ºC
on a 12 hour reversed light-dark cycle (lights on from 7 AM to 7PM).
Surgical Procedures
The animals were anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80
mg/kg and maintenance dose 40 mg/kg, via intramuscular) and xylazine (0.8 mg/kg, via
intramuscular). Anesthetized rats were fixed in stereotaxic frame (Kopf Instruments,
Tajunga, CA) and the incisor bar was adjusted until the anterior and posterior parts of
skull were at the same level. Stereotaxic coordinates of Paxinos and Watson atlas (2007)
were used and the reference point was bregma. Indwelling stainless bilateral steel 27-g
guide cannulae were implanted 1.5 mm above the MLR. The coordinates are in
millimeters: AP= ˗8, M= ±1.9, DV= ˗7 for MLR. These rats were kept in their cages for
a 7 days of recovery period.
Drugs
8OH-DPAT was purchased from Tocris Cookson (Ellisville, MO, USA).
Gait Studies
One day prior to surgery, all rats underwent Catwalk training to familiarize them to the
walkway and to ensure their ability in conducting successful gait trails.
Tight fitting 30-g bilateral injection cannulae were inserted into the guides. They
protruded 1.5 mm from the guide cannulae to reach the coordinates mentioned above for
the MLR. Infusions were carried out over 1 minute and the injection cannulae were kept
in place for another 60 seconds to minimize backflow.
On the first day of the experiment, 0.5µl of sterile 0.9% saline was injected in MLR. Five
minutes after the injection the animals were placed on Catwalk glass, where they were
able to walk freely with their normal pace. For each vehicle or drug injection for each
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animal, at least three successful gait trials were recorded. A gait trial is considered
successful if the animal starts walking from one side of the glass plate and finishes its gait
to the other side of the glass without turning back.
Baseline gait parameters were recorded after saline injection. An hour after the saline
injection, 5µM of sterile 8OH-DPAT (Pham-Le et al., 2011) was injected in the MLR.
Five minutes after the injection the rats were placed on Catwalk and their gait was
measured.
Histology
Upon completion of experiments, animals received an overdose of sodium pentobarbital
and were perfused transcardially with 0.9% NaCl (containing 1 ml/lit heparin) followed
by 4% formaldehyde solution (in 0.1 M phosphate buffer). The brains and spinal cords
were removed and stored in 4% formaldehyde solution for 48 hours and then, 26%
glycerol solution until they were settled.
To visualize colocalization of the CTB retrograde tracer (from animals in chapter 2, in
which CTB was microinjected in CPGs) with 5HT1A in the MLR, 40µm coronal sections
were cut using a microtome and every fifth section was stained for 5HT1A receptors.
A rabbit anti-5HT1A primary antibody (SR-1A Antibody, Santa Cruz Biotechnology) and
a Biotinylated Goat Anti-Rabbit IgG secondary Antibody (Vector Laboratories) were
used. Then sections were studied under Olympus FV1000 microscope.
To verify the placement of the cannulae, 0.5µl of a 4% methylene blue solution was
infused in the MLR. The extension of the dye after half an hour was considered as an
indication of the presumed diffusion of the normal saline or 8OH-DPAT, which was
given to each animal during the experiments. In this part of the experiment, 4 animals
with an inaccurate cannulae site were excluded from our study.
Statistical Analysis
In this study, gait parameters of six animals in each group were measured, similar studies
on Catwalk apparatus have shown that this number of the subjects provides a valid data
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set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015).
All the recorded videos were double-checked to correct any possible errors that the
Catwalk software might have made in labeling the paws. All walkway crossings were
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ±
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to
analyze all parameters. Statistical significance was evaluated by the Friedman Test and
group differences were determined by the non-parametric Wilcoxon test. Since the
number of the subjects we used in each group of the animals was small (n=6),
normalization of the data was not appropriate, therefore, we used Wilcoxon test which
does not assume normality in the data. In this study, a P value lower than 0.05 was
considered to be statistically significant.

5.3 « Results »
Verifying Cannulae Placement
Ten male Sprague-Dawley rats underwent surgery and double cannulas were inserted in
the MLR (mainly in the PPN). To verify the placement of the cannulas, 1µl of a 4%
methylene blue solution was infused through the cannulae and half an hour later animals
were sacrificed. Sections were prepared and the cannulae sites were verified under the
microscope (Figure12). Four of the animals were excluded due to an inaccurate cannulae
injection site.
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Figure12. Cannula site at the MLR. 0.5 µl Methylene blue 4% was microinjected
through cannula. After making sections Nissl Staining with neutral red color is done on
the sections. Two upper sections are presenting cannula site at caudal part (Right upper
image), and rostral part (left upper image) of the MLR in the same animal. Lower images
are higher magnification of upper sections’ injection site, black arrows show the injection
site.

Effect of 5HT1A agonist injection in MLR on gait.
The vehicle’s effect on gait was tested by bilateral injection of 0.5 µl normal saline in the
MLR and studying the rats’ gait on Catwalk. One hour after vehicle injection, 5µM of
8OH-DPAT, a 5HT1A receptor agonist was microinjected bilaterally (Pham-Le et al.,
2011) and the rats were placed on Catwalk. While we tested the rats on Catwalk, we
noticed several mild episodes of freezing of gait in rats. These freezing episodes caused
significant increase in body speed variation in all four limbs, P= 0.048 (Table9 and
Figure 13). Stand duration also increased but the swing phase duration did not change
significantly, which resulted in significant increase in duty cycle, which Expresses Stand
as a percentage of Step Cycle . In addition, there was a significant decrease in body
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speeds and stride length (Table 9). The key findings in this part of the study are
summarized in Figure 13.

Table9. Key Findings after injection of 5HT1A in MLR. Mean
± standard deviation is measured for each parameter in
individual limbs. P values <0.05 are considered significant and
are highlighted with light green color.
Dynamic Gait Parameters
Stand RF
Stand RH
Stand LF
Stand LH
Swing RF
Swing RH
Swing LF
Swing LH

Normal
Saline
0.3±0.05
0.35±0.07
0.3±0.05
0.3±0.05
0.16±0.02
0.13±0.009
0.16±0.01
0.12±0.02

Swing Speed RF
Swing Speed RH
Swing Speed LF
Swing Speed LH
Stride Length RF
Stride Length RH
Stride Length LF
Stride Length LH
Step Cycle RF
Step Cycle RH
Step Cycle LF
Step Cycle LH
Body Speed RF
Body Speed RH
Body Speed LF
Body Speed LH
Body Speed Variation RF
Body Speed Variation RH
Body Speed Variation LF
Body Speed Variation LH
Duty Cycle RF
Duty Cycle RH
Duty Cycle LF
Duty Cycle LH

51±8.1
57.8±7.4
50.9±7.09
62.1±9.6
7.46±0.67
7.35±0.63
7.48±0.75
7.5±0.51
0.46±0.07
0.46±0.07
0.47±0.07
0.46±0.06
15.96±3.07
16.02±3.18
15.76±3.5
15.9±2.6
30.9±13.08
33.09±9.35
31.5±12.3
32.39±12.7
64.1±2.66
68.5±4.25
63.5±2.88
70.6±6.06

8OH-DPAT
P value
0.046
0.51±0.14
0.046
0.62±0.14
0.046
0.5±0.17
0.046
0.5±0.17
0.075
0.19±0.03
0.345
0.13±0.009
0.028
0.22±0.03
0.917
0.127±0.001
0.028
39.8±5.3
52.3±8.05
38.4±5.1
54.1±5.3
6.5±0.73
6.75±0.63
6.45±0.49
6.7±0.55
0.71±0.14
0.77±0.18
0.73±0.16
0.75±0.15
11.07±2.04
11.6±2.4
11.3±1.9
11.5±1.7
55.8±17.4
59.9±18.09
57.46±16.9
58.68±20.7
67.9±4.78
76.4±2.38
63.7±6.03
77.1±3.5

0.173
0.028
0.116
0.028
0.028
0.028
0.028
0.028
0.028
0.028
0.028
0.028
0.028
0.028
0.028
0.046
0.046
0.046
0.046
0.046
0.028
0.753
0.028
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Stand Index RF
Stand Index RH
Stand Index LF
Stand Index LH

5.08±0.77
2.94±1.1
5.32±1.46
2.46±0.63

3.01±1.01
2.07±0.5
3.19±0.66
1.67±0.36

0.028
0.116
0.028
0.028

*

*
*

*

*

*

*

*

*

*

*
*

*

*
*
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*

*

Figure13. Key findings of the performance on
the Catwalk for dynamic gait parameters after
injection of normal saline, and 5HT1A agonist in
MLR. Graphs show group means ± SEM of
selected gait parameters. * p<0.05

*
*

*

*

Immunohistochemistry Labeling for 5HT1A in MLR.
After observing significant changes in gait by injection of 5HT1A agonist in the MLR, we
performed immunohistochemistry studies to find 5HT1A receptors on MLR neurons.
These neurons were already labeled with CTB injected in CPGs of the lumbar spinal cord
as described in chapter 2. We found a dense population of 5HT1A receptors in the MLR.
The images are shown in Figure 14.
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A

C

B

Figure 14. Double Labeling of the PPN
neurons for CTB tracer and 5HT1A receptor
antibody. (A) CTB was injected in CPGs in
the ventral horn of the spinal cord. CTB
vesicles in PPN neurons are seen in this
image. (B) PPN neurons stained for 5HT1A
receptor antibody. (C) Double staining of
PPN neurons for CTB and 5HT1A receptors
antibody. Scale bar = 50µm

5.4 « Discussion »
In this part of the study, we found that 5HT1A receptors on MLR neurons strictly control
their gait features. Activation of these receptors by 5HT1A agonist, 8OH-DPAT, resulted
in significant changes in dynamic gait parameters, but none of the static parameters.
Comparing this data to the results of chapter 3, where we inhibited DRN with lidocaine,
it seems that the patterns in which these two centers affect dynamic gait parameters are
different. Inhibition of the DRN resulted in significant increase in duration of both stand
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and swing phases, which lead to increase in step cycle duration. However, since the ratio
between stand and swing phases remained constant, there was no significant change in
duty cycle index, which measures stand as a percentage of step cycle. In contrast,
injection of 5HT1A agonist to the MLR resulted in significant increase in duty cycle due
to the increase in stand phase without altering swing phase duration.
In 1966, when Shik and colleagues identified the MLR for the first time, they also
emphasized a unique property of these neurons: increasing frequency of electrical
stimulation in these neurons resulted in increased speed (Orlovskiĭ, Severin, & Shik,
1966; Shik et al., 1966). In other words, by increasing the frequency, these animals
changed their gait pattern from walking to running, and eventually galloping.
Biomechanical gait analysis in different speeds showed that an increase in gait speed
leads to a decrease in stand duration, which decreases duty cycle. Moreover, by
decreasing the gait speed, stand duration increases and thus, duty cycle increases
(Hebenstreit et al., 2015). Therefore, biomechanical analysis of our rats gait after
injection of 5HT1A agonist in the MLR shows that the MLR determines the gait speed.
One of the main neurotransmitters in controlling the gait speed is serotonin.
But what makes the MLR and its components (PPN and cuneiform nucleus) appropriate
to control the gait speed? Recent studies suggest that the posterior part of the PPN
receives a considerable amount of fast sensory input, which it projects to the substantia
nigra pars compacta. These projections contain information about the value and salience
of the incoming sensory information received by the PPN (Hong & Hikosaka, 2014). As
a result, there is a potential role for PPN in gait due to its essential role in integration of
sensory information. For instance, MacLaren et al. showed that the PPN is not important
in fixed speed gait in rats. However, bilateral PPN cholinergic neuronal loss will result in
severely impaired gait on the accelerated rotarod. Gait on a fixed speed rotarod is
considered an automatic and reflexive behavior. However, a successful gait on an
accelerated speed rotarod requires the motor system to continuously adjust to changes
from incoming sensory inputs. In other words, one of the ways that the PPN adapts gait to
incoming sensory changes is by altering gait speed, stopping gait and initiating gait.
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In addition to a significant decrease in body speed, body speed variation increased and
stride length decreased significantly. These three changes are the essential features of an
abnormal gait in Parkinson disease patients. There are numerous postmortem studies
which suggest that there is a significant decrease in both DRN and PPN neurons in
patients in late stages of PD (Buddhala et al., 2015; Frisina, Haroutunian, & Libow, 2009;
Pienaar et al., 2013). Therefore, two main gait centers in the brainstem show severe
neurodegeneration by the time axial and gait symptoms start to emerge in PD patients.
To sum up, our studies and previous studies suggest that there are two main gait
controlling centers in the brainstem, the DRN and MLR. The DRN shows the highest
level of activity during wakefulness (specifically while the animal is moving) and lowest
level of activity during sleep (specifically during REM sleep when muscles are
completely atonic) (Aghajanian & Vandermaelen, 1982; Urbain et al., 2006). The DRN is
also important in footfall pattern and according to the literature, it controls it through
5HT2 receptors on the surface of motoneurons in the spinal cord (Aghajanian &
Vandermaelen, 1982; Courtine et al., 2009). Finally, our studies suggest that through
inhibition of the DRN with lidocaine, the regular footfall pattern disappears. Therefore,
we conclude that the DRN mainly controls automatic aspects of gait, which are not
dependent to dynamic changes of sensorimotor inputs. It also acts as a switch which turns
on or turns off the CPGs in the lumbar spinal cord. This depends on the general state of
animals in terms of mobility or immobility, as well as sleep and wakefulness.
On the other hand, the MLR is another brainstem center controlling gait. The MLR
receives fast sensory inputs from tracks of the spinal cord, in addition to extensive inputs
from basal ganglia structures such as the subthalamic nucleus and substantia nigra pars
reticulata. Thus, it seems the MLR mainly controls the aspects of gait that need intact
cognitive function, decision making, and goal orientation.
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Chapter 6
« Investigating the Role of 5HT1A receptors on Dorsal Raphe Nucleus
Neurons in Gait. »

6.1 « Introduction »
Previous studies have established that 5HT1A receptors are expressed on the surface of
serotonergic neurons in the DRN (Biegon, Rainbow, & McEwen, 1982; WeissmannNanopoulos, Mach, Magre, Demassey, & Pujol, 1985). The number of 5HT1A receptors
in the anterior part of the DRN is significantly higher than the posterior part (WeissmannNanopoulos et al., 1985), this gradient potentially correlates to the different roles of these
neurons. The DRN is known to be important in different disorders like depression,
addiction to drugs and alcohol, sleep disorders, and stress-related disorders (Chang et al.,
2011; Waselus, Valentino, & Van Bockstaele, 2011). Therefore, many studies are
focusing on the role of 5HT1A receptors in the pathophysiology of these disorders
(Gannon & Millan, 2006; Koprowska, Krotewicz, Romaniuk, Strzelczuk, & Wieczorek,
2002; You et al., 2015).
In previous chapters, we demonstrated that the DRN is controlling two important gait
centers in the brainstem: the MLR, and GiN. We hypothesized that 5HT1A receptors are
playing an important role in modulating the activity of DRN neurons in gait. To test our
hypothesis, we microinjected 8OH-DPAT, a 5HT1A agonist, in the DRN of rats and then
studied their gait by Catwalk apparatus.

6.2 « Material and Methods »
Six male Sprague-Dawley rats (10-12 weeks old), weighing 250-270 grams were used.
Rats were individually housed in Plexiglas-walled cages with free access to food and
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water throughout the experiment. The temperature of the room was kept at 22±1 ºC
on a 12 hour reversed dark-light cycle (lights on from 7 AM to 7PM).

Surgical Procedures
The animals were anaesthetized with ketamine hydrochloride (Vetalar, initial dose 80
mg/kg and maintenance dose 40 mg/kg, via intramuscular) and xylazine (0.8 mg/kg,
via intramuscular). Anesthetized rats were fixed in stereotaxic frame (Kopf
Instruments, Tajunga, CA) and the incisor bar was adjusted until the anterior and
posterior parts of skull were at the same level. Stereotaxic coordinates of Paxinos
and Watson atlas (2007) were used and the reference point was bregma. Indwelling
stainless steel 27-g guide cannulae were implanted 1.5 mm above the posterior
border of DRN. The coordinates are in millimeters: AP= ˗8.3, M=0, DV= ˗6.4 for
DRN. These rats were kept in their cages for a 7 days of recovery period.

Gait Studies
One day prior to surgery, all rats underwent Catwalk training to familiarize them to the
walkway and to ensure their ability in conducting successful gait trails.
Tight fitting 30-g injection cannulae were inserted into the guides. They protruded 1.5
mm from the guide cannulae to reach the coordinates mentioned above for the DRN.
Infusions were carried out over 1 minute and the injection cannulae were kept in place for
another 60 seconds to minimize backflow.
During the first day of the experiment, 0.5µl of sterile 0.9% saline was injected in the
DRN. Five minutes after the injection, the animals were placed on Catwalk, where they
were able to walk freely with their normal pace. For each vehicle or drug injection of
each animal, at least three successful gait trials were recorded. A gait trial is considered
successful if the animal starts walking from one side of the glass plate and finishes its gait
to the other side of the glass without turning back.
The vehicle’s effect on gait was tested by bilateral injection of 0.5 µl normal saline in the
DRN and studying the rats’ gait on Catwalk. An hour after the saline injection, 10µM of
8OH-DPAT, a 5HT1A receptor agonist, was injected in the DRN. Five minutes after the
injection, the rats were placed on Catwalk and their gait was measured.
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.
Histology
Upon completion of experiments, animals received an overdose of sodium pentobarbital
and were perfused transcardially with 0.9% NaCl (containing 1 ml/lit heparin) followed
by 4% formaldehyde solution (in 0.1 M phosphate buffer). The brains and spinal cords
were removed and kept in 4% formaldehyde solution for 48 hours and then, 26% glycerol
solution until they were settled.
To visualize colocalization of the CTB retrograde tracer (from animals in chapter 2, in
which CTB was microinjected in CPGs) with 5HT1A autoreceptors in the DRN, 40µm
coronal sections were cut using a microtome and every fifth section was stained for
5HT1A receptors.
Rabbit anti-5HT1A primary antibody (SR-1A Antibody, Santa Cruz Biotechnology) and a
Biotinylated Goat Anti-Rabbit IgG secondary Antibody (Vector Laboratories) were used.
Then sections were studied under Olympus FV1000 microscope.
To verify the placement of the cannulae, 0.5µl of a 4% methylene blue solution was
infused in the DRN. The extension of the dye after half an hour was considered as an
indication of the presumed diffusion of the normal saline or 8OH-DPAT, which was
given to each animal during the experiments.

Statistical Analysis

In this study, gait parameters of six animals in each group were measured, similar studies
on Catwalk apparatus have shown that this number of the subjects provides a valid data
set (Chuang et al., 2010; Mendes et al., 2015; Vandeputte et al., 2010; Zhou et al., 2015).
All the recorded videos were double-checked to correct any possible errors that the
Catwalk software might have made in labeling the paws. All walkway crossings were
analyzed using the Catwalk software data. Each gait parameter is expressed as mean ±
S.E.M (Standard error of the mean). SPSS statistical software (version 19) was used to
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analyze all parameters. Statistical significance was evaluated by the Friedman Test and
group differences were determined by the non-parametric Wilcoxon test. Since the
number of the subjects we used in each group of the animals was small (n=6),
normalization of the data was not appropriate, therefore, we used Wilcoxon test which
does not assume normality in the data. In this study, a P value lower than 0.05 was
considered to be statistically significant.

6.3 « Results »
Effect of 5HT1A agonist injection in DRN on gait.
The vehicle’s effect on gait was tested by injection of 0.5 µl normal saline in the DRN
and studying the rats’ gait on Catwalk. After injection of 10µM 8OH-DPAT, the rats
were placed on Catwalk and their gait was recorded. Statistical analysis of the data
showed that swing phase significantly decreased. Additionally, the data demonstrated that
swing speed increased in all limbs, but was only significant in the right hind and left front
limbs. There was no significant change in stance phase; however the changes in swing
and swing speed resulted in increased body speed while the forelimbs were actively
moving. The key findings are summarized in Table 10 and Figure15.

Table10. Selected gait parameters after injection of
8OH-DPAT in the DRN. Mean ± standard deviation is
measured for each parameter in individual limbs. P
values <0.05 are considered significant and are
highlighted with light green color.
Gait Parameters
Swing RF
Swing RH
Swing LF
Swing LH

Normal
Saline
0.271±0.08
0.187±0.04
0.275±0.1
0.192±0.06

8OH-DPAT
0.209±0.04
0.158±.02
0.225±0.05
0.161±0.02

P Value
0.046
0.046
0.468
0.435
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Swing Speed RF
Swing Speed RH
Swing Speed LF
Swing Speed LH
Body Speed RF
Body Speed RH
Body Speed LF
Body Speed LH

96.27±28.06
122.9±25
90.4±34.9
120.41±29.3
29.9±12.4
30.8±11.2
28.8±12.2
30.8±10.1

107.86±28.7
131.1±24.6
112.6±31.9
130.5±24.8
33.9±12.8
34.38±9.97
33.7±10.6
34.2±9.5

0.075
0.046
0.028
0.173
0.046
0.116
0.046
0.116

*

*

*

*

*
*

*

Figure15. Key Findings of the Performance on
Catwalk for Gait Parameters after injection of
Normal Saline, and 5HT1A Agonist in DRN.
Graphs show group means ± SEM of selected
gait parameters. * p<0.05
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Immunohistochemistry labeling for 5HT1A in MLR.
After significant changes in gait by injection of 5HT1A agonist in the DRN were found,
we performed immunohistochemistry studies to find 5HT1A receptors on DRN neurons,
which were already labeled with CTB injected in the GiN in the second chapter. We
found 5HT1A receptors on these neurons. The images are shown in Figure 16.

A

B
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C

Figure16. Double Labeling of DRN neurons for CTB tracer, and 5HT1A receptors
antibody. (A) CTB was injected in CPGs in GiN. CTB vesicles in DRN neurons are seen
in this image. (B) DRN neurons stained for 5HT1A receptor antibody. (C) Double staining
of DRN neurons for CTB and 5HT1A receptors antibody. Scale bar = 20µm

6.4

« Discussion »

In this part of the study, we found that 5HT1A receptors stimulation in the DRN changed
swing phases in gait cycle. Swing duration in all limbs decreased, but it was not
significant in the left front limb. Additionally, swing speed also increased, but they were
only significant in two limbs: right hind and left front limbs. These changes result in
increased body speed in anterior limbs while these limbs were actively moving. To avoid
affecting the MLR which are located anterolateral to DRN, we inserted cannulas in the
aqueduct canal and the needle tips of the injector cannulas were just touching the dorsal
border of the DRN. Therefore, there is a possibility that the drug is not distributed to all
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areas of the DRN and this fact might explain why significant changes in swing phase
appeared only in some limbs but not all four limbs.
There is an anteroposterior gradient in the density of 5HT1A receptors. The density is
higher in the ventral part compared to the dorsal part of the DRN. In chapter two, we
injected cholera toxin beta subunit, a neural retrograde tracer in the GiN, and we found
that the neurons which project to the GiN are mostly located in the posterior part of the
DRN. Therefore, a low density of 5HT1A receptors on serotonergic neurons sending
projections down to the GiN in our study is consistent with previous studies (WeissmannNanopoulos et al., 1985)
Since the DRN is known to play a crucial role in controlling sleep/wake cycles, mood,
stress level, and appetite (Chang et al., 2011; Waselus et al., 2011), several studies
are currently focusing on physiological mechanisms that control serotonergic
neurons in the DRN. 5HT1A receptors are important modulators of serotonergic
activity in the DRN, and studies have shown that these receptors might play an
important role in the pathophysiology of disorders like drug and alcohol abuse, sleep
disorders, and depression (Gannon & Millan, 2006; Koprowska et al., 2002; You et
al., 2015). Here we found that 5HT1A receptors in the DRN are also important in
controlling gait by affecting swing phase. However, due to the low density of these
receptors on serotonergic neurons that control gait, they might not be as important in
gait as they are in controlling other DRN functions.
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Chapter 7

7

« General Discussion »

The main findings in this study are listed here: 1) The DRN, MLR, and GiN, project
directly to the ventral horn of the lumbar spinal cord where lower motoneurons and CPGs
for locomotion are located (Chapter 2). 2) The DRN also sends projections to the GiN,
however, MLR does not send projections to the GiN (Chapter 2). 3) Inhibition of the
neurons in the DRN with lidocaine resulted in significant changes in both static and
dynamic gait parameters (Chapter 3). 3) The DRN affects static gait parameters through
its projections to the GiN, and 5HT1A receptors on GiN neurons are responsible for this
effect (Chapter 4). 4) There is a dense population of 5HT1A receptors on MLR, and
activation of these receptors with 8OH-DPAT, a 5HT1A specific agonist, resulted in
significant changes in almost all dynamic gait parameters tested but none of the static
parameters were changed (Chapter 5). 5) 5HT1A receptors are also present on the surface
of the neurons in the DRN, while their effect on gait was limited to the swing phase of
the gait cycle (Chapter 6). The main findings of this study are summarized in Figure 17.
The effect of the direct projections from the DRN to the motoneurons in the ventral horn
of the spinal cord are well studied (Barreiro-Iglesias et al., 2008; Ghosh & Pearse, 2015),
and it has been proposed that this pathway might facilitate activation of the motoneurons
and CPGs. Consequently, by inhibiting DRN neurons directly with lidocaine, we
expected to see impairment in dynamic gait parameters; however, we found that both
dynamic and static gait parameters were impaired.
In addition, DRN neurons projected directly to the lower motoneurons and locomotor
CPGs in the ventral horn of the spinal cord. We identified a novel pathway from DRN to
the GiN. The DRN neurons send projections to the medial part of the rostral medulla,
where GiN is located. Prior literature has shown that electrical stimulation of the neurons
at GiN, resulted in changes in muscle tone during both sleep, and awake state (Lai et al.,
2010). The discovery of the pathway from the DRN to the GiN in the current study may
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explain the changes we saw in static gait parameters after injections of the lidocaine in
the DRN. To clarify the role of this new pathway in gait and to identify the types of the
serotonergic receptors on GiN neurons, we have investigated the effect of agonists and
antagonists for 5HT1A and 5HT2 receptors, respectively. The Catwalk study results
suggested that 5HT1A receptors are at least one of the serotonergic receptors controlling
the gait parameters in the GiN when animals walk freely.
Prior studies have shown that PPN and specifically cholinergic neurons in the PPN send
projections to the GiN (Bachmann et al., 2013; Rye et al., 1988; Skinner & Garcia-Rill,
1984). Previous studies of the PPN and MLR investigating gait, failed to find changes in
muscle tone and static gait parameters following destruction, inhibition or stimulation of
these structures (Bachmann et al., 2013; MacLaren et al., 2014; Smetana et al., 2010;
Wen et al., 2015). In a recent study, Gut et al. (Gut & Winn, 2015) employed Catwalk
method to measure different gait parameters in the 6-OHDA model of PD rats with
partial or complete PPN lesions. They only found significant changes in stride length,
swing speed, and duty cycle of these rats. These changes improved after posterior PPN
deep brain stimulation and worsened with anterior PPN stimulation. However, they did
not report any changes in any static gait parameters.
In this study, we injected the retrograde tracer CTB in the GiN, but only DRN neurons in
the mesopontine junction were labeled for the tracer, and the number of the neurons in
the MLR which were labeled from the tracer was negligible. Although we did not find a
pathway from the MLR to the GiN, instead, we found that a considerable number of
neurons in the MLR send direct projections to the lower motor neurons and the CPGs of
the lumbar spinal cord. In agreement with this, a recent study by Sherman et al. (Sherman
et al., 2015) showed that the MLR in the mesopontine junction does not send projections
to the medullary reticular formation, rather sends direct projections down to the spinal
cord motoneurons.
We then tested the effect of 5HT1A agonist in the MLR while the animals were walking
on the Catwalk. We found that the body speed and the stride length were significantly
decreased. Meanwhile, the ratio between the stand phase duration and the step cycle
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duration were changed, indicating changes in the gait pattern. These findings might be
explained by the direct projections from the MLR to the lower motoneurons and CPGs of
the lumbar spinal cord we found in the present study.
In addition, PPN also receives extensive inputs from basal ganglia structures such as the
subthalamic nucleus and substantia nigra pars reticulata (Child & Benarroch, 2013;
Sherman et al., 2015; Tattersall et al., 2014). As a result, there is a potential role for PPN
in controlling the aspects of the gait that are dependent on intact decision making and
cognitive function of the brain.
To sum up, our results along with previous findings indicate that there are two main gait
controlling centers in the brainstem, namely, the DRN and MLR (Figure 17). The DRN
shows the highest level of activity during wakefulness (specially, while the animal is
moving) and lowest level of activity during sleep (specially, during REM sleep when
muscles are atonic) (Aghajanian & Vandermaelen, 1982; Urbain et al., 2006). The DRN
is also important in mediating the foot-fall pattern via 5HT2 receptors on the surface of
motoneurons in the spinal cord (Aghajanian & Vandermaelen, 1982; Courtine et al.,
2009). Finally, our studies suggest that through inhibition of the DRN with lidocaine, the
normal foot-fall pattern disappears. Therefore, we conclude that the DRN mainly controls
automatic aspects of gait, which are not dependent to dynamic changes of sensorimotor
inputs. In addition, it may act as a switch which turns on or turns off the CPGs in the
lumbar spinal cord. This depends on the general state of animals in terms of mobility or
immobility, as well as sleep and wakefulness.
On the other hand, the MLR is another brainstem center controlling gait. The MLR
receives fast sensory inputs from the spinal cord, in addition to extensive inputs from
basal ganglia structures such as the subthalamic nucleus and substantia nigra pars
reticulata. Thus, it seems that the MLR mainly controls the aspects of gait that require
intact cognitive function, decision making, and goal-orientated.
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Figure17. A proposed circuitry controlling gait parameters. DRN sends projections to the
GiN, ventral horn of the spinal cord and possibly to the MLR. DRN controls the static gait
parameters through its projections to the GiN, and controls dynamic gait parameters though
possible projections to the MLR. LMN: Lower Motor Neurons

Parkinsonian gait is characterized as slow gait with short steps. We found the similar gait
pattern in our rats after the injection of 5HT1A agonist, in the MLR: there was a
significant decrease in body speed, and stride length, and a significant increase in body
speed variation. Based on these findings, degeneration of the DRN or PPN or both of
these structures will result in the abnormal gait pattern we saw after activation of 5HT1A
receptors in MLR. Post-mortem studies indicate a significant loss of both DRN and PPN
neurons in late stages of PD (Buddhala et al., 2015; Frisina et al., 2009; Pienaar et al.,
2013). Clinical trials suggest that there are a considerable number of patients who do not
show improvement in gait and axial symptoms after the deep brain stimulation of the
PPN. In these patients, degeneration of the DRN neurons might be responsible for these
symptoms.
Limitations of the Study
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The DRN is located dorsomedial to the MLR. To study the effect of the drugs on DRN
without affecting the function of the MLR, cannulas targeting the DRN were
inserted in the aqueduct canal and the tip of the injector cannulas were located near
the dorsal border of the DRN. The animal’s gait was measured only five minutes
after the injection, but it is possible that the drugs leak through the aqueduct canal to
the adjacent structures like the cerebellum.
While Catwalk apparatus measures many gait parameters, there is no parameter to
measure the freezing episodes. The only parameter that indirectly indicates the
freezing episodes is body speed variation which was increased significantly while
animals had freezing. However, the Catwalk software is programmed to measure
the gait parameters when the animals are actively moving, therefore, the effect of
gait freezing episodes on other gait parameters is not substantial.
Conclusions
All these findings together suggest that the DRN serotonergic neurons are one of the
main controllers of the gait. These neurons send projections to at least three areas: The
GiN, the ventral horn of the spinal cord, and possibly to the MLR. While they facilitate
the activity of motoneurons and CPGs through their direct projections to the ventral horn
of the spinal cord, they modulate static gait parameters through their projections to the
GiN, and also modulate the dynamic gait parameters through their possible projections to
the MLR.
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